The stocks of these two developmental concerns have slid recently, but there are reasons to believe they will improve.
That's why I always act incrementally when allocating new funds to the market or raising cash in my portfolio.
Plus an update on my SPX and Nike plays.
Prices went vertical early this month on heavy volume.
Ironically, some experts now see biotech as a safe haven as the sector remains unaffected by trade wars and other global headwinds.
In the short run the stock of this biotech giant could bounce as momentum has slowed, but the bigger picture is for further weakness.
What are insiders buying as the market sells off in recent trading sessions?
The stock purchases by the insiders are at companies developing treatments for breast cancer and schizophrenia.
Few parts of this biotech space are more frustrating that what I have dubbed 'Tier 3' biotech concerns.
I am incrementally using buy-write option orders to add some shares to core holdings.